Glycemic outcomes of people with diabetes mellitus in Brazilian primary health care

[1] Yang W(2018)Economic costs of diabetes in the U.S. in 2017 Diabetes Care 41 917-28

[2] Dall TM(2017)Noncommunicable diseases and the use of health services: Analysis of the National Health Survey in Brazil Rev Saude Publica 51 1-10

[3] Beronjia K(2019)Diabetes mellitus mortality in a municipality in the state of São Paulo, 2010 to 2014 Rev Saude Publica 53 1-9

[4] Lin J(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853

[5] Semilla AP(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 321 405-412

[6] Chakrabarti R(2021)6. Glycemic Targets: Standards of Medical Care in Diabetes - 2021 Diabetes Care 44 73-84

[7] Malta DC(2018)Achievement of guideline targets for blood pressure, lipid, and glycemic control in type 2 diabetes: A meta-analysis Diabetes Res Clin Pract 137 137-148

[8] Bernal RTI(2019)Trends in the prevalence and management of diabetes in Korea: 2007–2017 Epidemiol Health 41 e2019029-9

[9] Lima MG(2020)Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016 Salud Publica Mex 62 50-7

[10] de Araújo SSC(2019)Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels Int J Clin 73 1-1006

[1] Yang W(2018)Economic costs of diabetes in the U.S. in 2017 Diabetes Care 41 917-28

[2] Dall TM(2017)Noncommunicable diseases and the use of health services: Analysis of the National Health Survey in Brazil Rev Saude Publica 51 1-10

[3] Beronjia K(2019)Diabetes mellitus mortality in a municipality in the state of São Paulo, 2010 to 2014 Rev Saude Publica 53 1-9

[4] Lin J(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853

[5] Semilla AP(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 321 405-412

[6] Chakrabarti R(2021)6. Glycemic Targets: Standards of Medical Care in Diabetes - 2021 Diabetes Care 44 73-84

[7] Malta DC(2018)Achievement of guideline targets for blood pressure, lipid, and glycemic control in type 2 diabetes: A meta-analysis Diabetes Res Clin Pract 137 137-148

[8] Bernal RTI(2019)Trends in the prevalence and management of diabetes in Korea: 2007–2017 Epidemiol Health 41 e2019029-9

[9] Lima MG(2020)Prevalence of diabetes and poor glycemic control in Mexico: results from Ensanut 2016 Salud Publica Mex 62 50-7

[10] de Araújo SSC(2019)Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels Int J Clin 73 1-1006